<DOC>
	<DOCNO>NCT02893787</DOCNO>
	<brief_summary>The main goal study compare value echocardiographic parameter obtain Speckle Traking analysis myocardial function among patient 18 year treat anthracyclines childhood , healthy age sex mached volunteer .</brief_summary>
	<brief_title>Study Myocardial Function Speckle Tracking After Cancer Treatment With Anthracyclines Childhood</brief_title>
	<detailed_description>Anthracyclines major drug treatment childhood cancer . The main factor limit use occurrence delay cardiac toxicity , irreversible , dilated form potentially fatal cardiomyopathy . This delayed cardiotoxicity secondary destruction myocardial cell histologically proven administration first dose anthracyclines . The main known risk factor delay cardiotoxicity : cumulative dose anthracyclines , young age time administration , association mediastinal radiotherapy . All pediatric protocol anthracyclines therefore provide prolonged cardiac monitoring . However , validate predictive early marker progression cardiomyopathy : ) standard echocardiography , routine surveillance method detect subclinical myocardial injury , ii ) predictive value biomarkers ( ultrasensitive troponin , NT-pro-BNP ) controversial conflict result . Among echocardiographic innovative technique , myocardial strain image speckle track echocardiography analysis via software myocardial displacement natural acoustic marker , enables rapid evaluation , precise objective segmental global myocardial function , express percentage ( strain ) speed myocardial deformation ( strain rate ) reference segment reference dimension ( longitudinal , radial , circumferential ) . Only four recent study analyse myocardic function ST patient treat anthracyclines childhood ( Yiu-fai , Cheung , Yu W , Poterucha ) find unmatched and/or incomplete result , limited number patient , suggest existence alteration leave ventricle strain appearance deterioration fraction ejection leave ventricle ( LVEF ) . None study study strain right ventricle none compare data strain cardiac biomarkers . Primary objective Compare value echocardiographic parameter obtain technique ST myocardial function among patient 18 year treat anthracyclines childhood , healthy age sex mached volunteer . Secondary objective To compare conventional echocardiographic parameter ST term deviation norm To assess impact know risk factor cardiotoxicity anthracyclines ( cumulative dose , young age administration , female association mediastinal radiotherapy ) ultrasound parameter obtain technique ST. To evaluate association biomarkers cardiotoxicity ( ultrasensitive troponin NT-pro-BNP ) echocardiographic parameter obtain technique ST. To correlate index Speckle Tracking method classical sonographic data</detailed_description>
	<criteria>Inclusion criterion : Patient treat 0 18 anthracyclines malignancy Discontinuation treatment chemotherapy 1 year Patient remission malignancy Lack heart lung disease associate No opposition patient legal guardian Patient young 18 time study . Exclusion criterion : Progressive malignant pathology . Cardiac , lung muscle chronic disease , etiology secondary treatment anthracyclines Refusal participate study Poor echogenicity</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Speckle Tracking</keyword>
	<keyword>Anthracyclines</keyword>
	<keyword>Chilhood cancer</keyword>
	<keyword>Myocardial function</keyword>
	<keyword>Echocardiography</keyword>
</DOC>